Enzalutamide

Enzalutamide is a type of anti-androgen drug that is used in the treatment of prostate cancer. It works by blocking the action of androgens, which are hormones that can cause the cancer cells to grow. Enzalutamide is approved for use in men with prostate cancer that has spread to other parts of the body and is no longer responding to hormone therapy. It can also be used to treat men with advanced prostate cancer that has not yet spread. Enzalutamide is an effective treatment for prostate cancer and provides patients with an alternative to chemotherapy or radiation therapy. It has significantly improved the quality of life for many men with advanced prostate cancer.

← International Journal of Prostate Cancer

Related Articles

1 journal(s) found

International Journal of Prostate Cancer

ISSN: Coming Soon
Type: Open Access Journal
Editor: Sam J. Brancato , Holden Comprehensive Cancer Center.
International Journal of Prostate Cancer is a world -wide, peer-reviewed open access journal. The main aim of this journal is to dedicate basic and clinical studies on prostate cancer and to provide rapid turn-around time possible for reviewing and publishing articles. Authors are encouraged to write - up research articles, review, letters, short-c